Sika Stock - JPMorgan lifts rating after reassessing margin risks

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 09:30 UTC. Details in the imprint.

Sika (CH0418792922) is back on JPMorgan’s radar with a friendlier stance. The US bank has upgraded the Swiss construction chemicals group to Neutral and lifted its December 2027 price target, arguing margin risks are now largely priced in, according to an Investing.com summary of the JPMorgan note.

What JPMorgan changed

According to the Investing.com write-up, JPMorgan has moved its rating on Sika from Underweight to Neutral and removed the stock from its Negative Catalyst Watch list, signaling a more balanced risk-reward view.

The bank also raised its Sika price target for December 2027 from CHF 140 to CHF 165, applying a higher valuation multiple as it sees “limited further downside earnings risk” after recent margin concerns were digested by the market.

Long-term margin and growth story

JPMorgan’s argument centers on Sika’s ability to defend and gradually expand margins over its multi-year plan, supported by synergies from recent acquisitions and a continued shift toward higher-value solutions in construction and industrial applications.

The bank still flags macro sensitivity across Europe, the United States and China, but believes volume and pricing risks are now broadly reflected in consensus expectations, making the risk profile more symmetric for long-term investors.

How the company makes money

Sika generates most of its revenue from specialty construction chemicals, including concrete admixtures, mortars, waterproofing systems and roofing membranes, as well as adhesives and sealants for automotive and industrial customers worldwide.

Where the stock trades today

Sika shares trade on SIX Swiss Exchange at CHF 275.10 as of 06/20/2026, 09:30 CET.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.